CAS: 381717-91-5
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
4-benzoyl-5-(4-chlorophenyl)-3-hydroxy-1-[3-(1H-imidazol-1-yl)propyl]-2,5-dihydro-1H-pyrrol-2-one REF: IN-DA0296WFCAS: 381717-91-5 | 98% | A consultar | Jue 05 Dic 24 | |
p53-MDM2-IN-1 REF: TM-T72026CAS: 381717-91-5 | 98.3% | 182,00 €~3.686,00 € | Jue 23 Ene 25 | |
4-Benzoyl-5-(4-chlorophenyl)-3-hydroxy-1-[3-(1H-imidazol-1-yl)propyl]-2,5-dihydro-1H-pyrrol-2-one REF: 3D-GQA71791CAS: 381717-91-5 | Min. 95% | - - - | Producto descatalogado |
4-benzoyl-5-(4-chlorophenyl)-3-hydroxy-1-[3-(1H-imidazol-1-yl)propyl]-2,5-dihydro-1H-pyrrol-2-one
CAS:381717-91-5
Fórmula:
C23H20ClN3O3
Pureza:
98%
Peso molecular:
421.8762
Ref: IN-DA0296WF
10mg | 183,00 € | ||
25mg | 260,00 € | ||
50mg | 584,00 € | ||
100mg | A consultar | ||
250mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 5 de Diciembre de 2024
p53-MDM2-IN-1
CAS:381717-91-5
p53-MDM2-IN-1 (Example 30), an inhibitor targeting the p53-MDM2/X protein interaction, exhibits a K i value …
Fórmula:
C23H20ClN3O3
Pureza:
98.3%
Forma y color:
Soild
Peso molecular:
421.88
Ref: TM-T72026
1mg | 182,00 € | ||
5mg | 455,00 € | ||
10mg | 664,00 € | ||
25mg | 1.019,00 € | ||
50mg | 1.374,00 € | ||
100mg | 1.850,00 € | ||
500mg | 3.686,00 € |
Entrega estimada en Estados Unidos, el Jueves 23 de Enero de 2025
4-Benzoyl-5-(4-chlorophenyl)-3-hydroxy-1-[3-(1H-imidazol-1-yl)propyl]-2,5-dihydro-1H-pyrrol-2-one
CAS:381717-91-5
Please enquire for more information about 4-Benzoyl-5-(4-chlorophenyl)-3-hydroxy-1-[3-(1H-imidazol-1-yl)propyl]-2,5-dihydro-1H-pyrrol-2-one including the price, delivery time and more detailed …
Fórmula:
C23H20ClN3O3
Pureza:
Min. 95%
Peso molecular:
421.9 g/mol
Ref: 3D-GQA71791
10mg | Descatalogado | Solicitar información | |
25mg | Descatalogado | Solicitar información | |
50mg | Descatalogado | Solicitar información | |
100mg | Descatalogado | Solicitar información | |
250mg | Descatalogado | Solicitar información | |
500mg | Descatalogado | Solicitar información |